All News
STAT+: Medicare Advantage enrollment growth slows drastically
Enrollment in private Medicare Advantage plans grew just 3.1%, below projections from Wall Street or the government.
Read MoreMy $30,000 health insurance claim was denied. Then I tweeted about it
Public shaming works – but it’s also a sign of how broken the appeals process is in the US health insurance industryIn December 2016, I was hospitalized with severe electrolyte abnormalities that
Read MoreWill They Come for PubMed Next?
(MedPage Today) -- PubMed is the backbone of biomedical research in the U.S. That's not an exaggeration.
Read MoreUnvaccinated Child Dies of Measles in Texas, Officials Say
At least 124 cases of measles have been identified in Texas since late January, mostly among children and teenagers who are either unvaccinated or whose vaccination status is unknown, officials say.
Read MoreTeens Speak Out After Gender Surgery Pause; Sepsis Rate Jumps Following Abortion Ban
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Read MoreTexas measles outbreak marks first fatality as more cases reported
A child in Texas has died from measles, the first death from measles in the United States since 2015.
Read MoreFired Cybersecurity Chief for VA Site Warns Health and Financial Data Are at Risk
(MedPage Today) -- Sensitive financial and health data belonging to millions of veterans and stored on a benefits website are at risk of being stolen or otherwise compromised, according to a federal
Read MoreSocial media influencers are ‘fearmongering’ to promote health tests with limited evidence, study finds
Researchers warn of harms of overdiagnosis for generally healthy people as well as the cost of tests themselvesInfluencers are appealing to emotional narratives around health and often “fearmongerin
Read MoreFDA Eliminates Barrier to Clozapine, Plans to End REMS Program
(MedPage Today) -- The FDA no longer expects prescribers, pharmacies, and patients to participate in the risk evaluation and mitigation strategy (REMS) program for the antipsychotic clozapine, the ag
Read MoreSTAT+: Are we adopting AI scribes based on… vibes?
The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.
Read More